GnRH-deficient phenotypes in humans and mice with heterozygous variants in KISS1/Kiss1.
Chan. Yee-Ming YM; Broder-Fingert. Sarabeth S; Paraschos. Sophia S; Lapatto. Risto R; Au. Margaret M; Hughes. Virginia V; Bianco. Suzy D C SD; Min. Le L; Plummer. Lacey L; Cerrato. Felecia F; De Guillebon. Adelaide A; Wu. I-Hsuan IH; Wahab. Fazal F; Dwyer. Andrew A; Kirsch. Susan S; Quinton. Richard R; Cheetham. Timothy T; Ozata. Metin M; Ten. Svetlana S; Chanoine. Jean-Pierre JP; Pitteloud. Nelly N; Martin. Kathryn A KA; Schiffmann. Raphael R; Van der Kamp. Hetty J HJ; Nader. Shahla S; Hall. Janet E JE; Kaiser. Ursula B UB; Seminara. Stephanie B SB
Key Findings
- Rare heterozygous KISS1 variants were identified in a small subset of GnRH‑deficient patients.
- Variants within the mature kisspeptin peptide (e.g., p.F117L) reduce cellular signaling activity.
- Mice with one‑copy loss of Kiss1/Kiss1r show lower testosterone, altered sexual development, and reduced fertility.
Practical Outcomes
- For most biohackers, this study doesn’t change how to use kisspeptin‑10. It suggests that genetic differences, not dosage, may affect reproductive hormone levels, so personal genetic testing could explain unexplained fertility or hormone issues, but no new supplementation protocol is recommended.
Summary
Scientists found rare changes in the KISS1 gene that can lower hormone signals needed for reproduction, and mice with similar gene changes have lower testosterone and reproductive problems. These findings mainly explain why some people have reproductive issues, but they don’t give a clear way to use kisspeptin‑10 for health or performance improvements.
Abstract
KISS1 is a candidate gene for GnRH deficiency. Our objective was to identify deleterious mutations in KISS1. DNA sequencing and assessment of the effects of rare sequence variants (RSV) were conducted in 1025 probands with GnRH-deficient conditions. Fifteen probands harbored 10 heterozygous RSV in KISS1 seen in less than 1% of control subjects. Of the variants that reside within the mature kisspeptin peptide, p.F117L (but not p.S77I, p.Q82K, p.H90D, or p.P110T) reduces inositol phosphate generation. Of the variants that lie within the coding region but outside the mature peptide, p.G35S and p.C53R (but not p.A129V) are predicted in silico to be deleterious. Of the variants that lie outside the coding region, one (g.1-3659C→T) impairs transcription in vitro, and another (c.1-7C→T) lies within the consensus Kozak sequence. Of five probands tested, four had abnormal baseline LH pulse patterns. In mice, testosterone decreases with heterozygous loss of Kiss1 and Kiss1r alleles (wild-type, 274 ± 99, to double heterozygotes, 69 ± 16 ng/dl; r(2) = 0.13; P = 0.03). Kiss1/Kiss1r double-heterozygote males have shorter anogenital distances (13.0 ± 0.2 vs. 15.6 ± 0.2 mm at P34, P < 0.001), females have longer estrous cycles (7.4 ± 0.2 vs. 5.6 ± 0.2 d, P < 0.01), and mating pairs have decreased litter frequency (0.59 ± 0.09 vs. 0.71 ± 0.06 litters/month, P < 0.04) and size (3.5 ± 0.2 vs. 5.4 ± 0.3 pups/litter, P < 0.001) compared with wild-type mice. Deleterious, heterozygous RSV in KISS1 exist at a low frequency in GnRH-deficient patients as well as in the general population in presumably normal individuals. As in Kiss1(+/-)/Kiss1r(+/-) mice, heterozygous KISS1 variants in humans may work with other genetic and/or environmental factors to cause abnormal reproductive function.
Study Information
pubmed
2011
2011-08-31T00:00:00.000Z
10.1210/jc.2011-0518
63
45